Thyroid cancer: SEOM clinical guidelines

por Trigo, J. M., Capdevila, J., Grande, E., Grau, J., Lianes, P.
Publicado en Clin Transl Oncol (2014)

Feeling angry about current health status: using a population survey to determine the association with demographic, health and social factors

por Gill, Tiffany K., Price, K., Dal Grande, E., Daly, A., Taylor, A. W.
Publicado en BMC Public Health (2016)

Population levels of wellbeing and the association with social capital

por Taylor, A. W., Kelly, G., Dal Grande, E., Kelly, D., Marin, T., Hey, N., Burke, K. J., Licinio, J.
Publicado en BMC Psychol (2017)

Comparison of Health and Risk Factors of Older, Working-age Australians, Italians and Italian-born Migrants to Australia, with Data from an Italian (PASSI), and an Australian (SAMS...

por Taylor, A. W., Grande, E. Dal, Fateh-Moghadam, P., Montgomerie, A., Battisti, L., Barrie, H., Kourbelis, C., Campostrini, S.
Publicado en J Immigr Minor Health (2017)

1ISG-021 Procedural kits with medical devices for eye surgery: optimisation strategy

por Isoardo, A, Dutto, R, Mondini, M, Ferrero, MM, Grande, E, Infante, L, Perlo, G, Crea, M, Viglione, M, Fruttero, C
Publicado en Eur J Hosp Pharm (2018)

Consensus document on the progression and treatment response criteria in gastroenteropancreatic neuroendocrine tumors

por Merino-Casabiel, X., Aller, J., Arbizu, J., García-Figueiras, R., González, C., Grande, E., Jiménez-Fonseca, P., Sevilla, M. I., Capdevila, J.
Publicado en Clin Transl Oncol (2018)

Uso de fármacos para la osteoporosis en pacientes con diabetes mellitus tipo 2: estudio de cohortes de base poblacional

por Martínez-Laguna D, Reyes C, Carbonell-Abella C, Losada Grande E, Soldevila Madorell B, Mauricio D, Díez-Pérez A, Nogués X, Prieto-Alhambra D
Publicado 2017-11-01

HIF pathway and c-Myc as biomarkers for response to sunitinib in metastatic clear-cell renal cell carcinoma

por Maroto, P, Esteban, E, Parra, E Fernández, Mendez-Vidal, MJ, Domenech, M, Pérez-Valderrama, B, Calderero, V, Pérez-Gracia, JL, Grande, E, Algaba, F
Publicado en Onco Targets Ther (2017)

ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups

por Quinn, D.I., Ng, C.F., Grande, E., Kwon, T.G., Linke, R., Lee, J.-L., Rosbrook, B., Thakur, M.N., Eto, M., Gross-Goupil, M.
Publicado en ESMO Open (2021)

Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-α as first-line systemic therapy for patients with metastatic renal cell carcinoma in a Eu...

por Castellano, D., del Muro, X. Garcia, Pérez-Gracia, J. L., González-Larriba, J. L., Abrio, M. V., Ruiz, M. A., Pardo, A., Guzmán, C., Cerezo, S. Díaz, Grande, E.
Publicado 2009

SEOM clinical guideline for treatment of kidney cancer (2017)

por Gallardo, E., Méndez-Vidal, M. J., Pérez-Gracia, J. L., Sepúlveda-Sánchez, J. M., Campayo, M., Chirivella-González, I., García-del-Muro, X., González-del-Alba, A., Grande, E., Suárez, C.
Publicado en Clin Transl Oncol (2017)

Correction to: SEOM clinical guideline for treatment of kidney cancer (2017)

por Gallardo, E., Méndez-Vidal, M. J., Pérez-Gracia, J. L., Sepúlveda-Sánchez, J. M., Campayo, M., Chirivella-González, I., García-del-Muro, X., González-del-Alba, A., Grande, E., Suárez, C.
Publicado en Clin Transl Oncol (2019)

MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines

por Arriola, E, Cañadas, I, Arumí-Uría, M, Dómine, M, Lopez-Vilariño, J A, Arpí, O, Salido, M, Menéndez, S, Grande, E, Hirsch, F R, Serrano, S, Bellosillo, B, Rojo, F, Rovira, A, Albanell, J
Publicado 2011

Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial

por Gross-Goupil, M, Kwon, T G, Eto, M, Ye, D, Miyake, H, Seo, S I, Byun, S -S, Lee, J L, Master, V, Jin, J, DeBenedetto, R, Linke, R, Casey, M, Rosbrook, B, Lechuga, M, Valota, O, Grande, E, Quinn, D I
Publicado en Ann Oncol (2018)

First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumo...

por Carrato, A., Benavides, M., Massutí, B., Ferreiro-Monteagudo, R., García Alfonso, P., Falcó, E., Reboredo, M., Cano, T., Gallego, J., Viéitez, J. M., Layos, L., Salud, A., Polo, E., Dotor, E., Durán-Ogalla, G., Rodriguez-Garrote, M., Calvo, A., Grande, E., Aranda, E.
Publicado en BMC Cancer (2019)

Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS)

por Grivas, P., Loriot, Y., Morales-Barrera, R., Teo, M. Y., Zakharia, Y., Feyerabend, S., Vogelzang, N. J., Grande, E., Adra, N., Alva, A., Necchi, A., Rodriguez-Vida, A., Gupta, S., Josephs, D. H., Srinivas, S., Wride, K., Thomas, D., Simmons, A., Loehr, A., Dusek, R. L., Nepert, D., Chowdhury, S.
Publicado en BMC Cancer (2021)

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative b...

por Conteduca, V., Wetterskog, D., Sharabiani, M. T. A., Grande, E., Fernandez-Perez, M. P., Jayaram, A., Salvi, S., Castellano, D., Romanel, A., Lolli, C., Casadio, V., Gurioli, G., Amadori, D., Font, A., Vazquez-Estevez, S., González del Alba, A., Mellado, B., Fernandez-Calvo, O., Méndez-Vidal, M. J., Climent, M. A., Duran, I., Gallardo, E., Rodriguez, A., Santander, C., Sáez, M. I., Puente, J., Gasi Tandefelt, D., Wingate, A., Dearnaley, D., Demichelis, F., De Giorgi, U., Gonzalez-Billalabeitia, E., Attard, G.
Publicado en Ann Oncol (2017)

Phase 3 Trial of (177)Lu-Dotatate for Midgut Neuroendocrine Tumors

por Strosberg, J., El-Haddad, G., Wolin, E., Hendifar, A., Yao, J., Chasen, B., Mittra, E., Kunz, P.L., Kulke, M.H., Jacene, H., Bushnell, D., O'Dorisio, T.M., Baum, R.P., Kulkarni, H.R., Caplin, M., Lebtahi, R., Hobday, T., Delpassand, E., Van Cutsem, E., Benson, A., Srirajaskanthan, R., Pavel, M., Mora, J., Berlin, J., Grande, E., Reed, N., Seregni, E., Öberg, K., Sierra, M. Lopera, Santoro, P., Thevenet, T., Erion, J.L., Ruszniewski, P., Kwekkeboom, D., Krenning, E.
Publicado en N Engl J Med (2017)

Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper

por Casali, P. G., Bruzzi, P., Bogaerts, J., Blay, J.-Y., Aapro, M., Adamous, A., Berruti, A., Blay, J.-Y., Bogaerts, J., Bressington, J., Bruzzi, B., Capocaccia, R., Cardoso, F., Casali, P. G., Celis, J. E., Cervantes, A., Ciardiello, F., Claussen, C., Coleman, M., Comis, S., Craine, S., De Boltz, D., De Lorenzo, F., Dei Tos, A. P., Gatta, G., Geissler, J., Giuliani, R., Grande, E., Gronchi, A., Jezdic, S., Jonsson, B., Jost, L., Keulen, H., Lacombe, D., Lamory, G., Le Cam, Y., Leto di Priolo, S., Licitra, L., Macchia, F., Margulies, A., Marreaud, S., McVie, G., Narbutas, S., Oliver, K., Pavlidis, N., Pelouchova, J., Pentheroudakis, G., Piccart, M., Pierotti, M. A., Pravettoni, G., Redmond, K., Riegman, P., Ruffilli, M. P., Ryner, D., Sandrucci, S., Seymour, M., Torri, V., Trama, A., Van Belle, S., Vassal, G., Wartenberg, M., Watts, C., Wilson, A., Yared, W.
Publicado en Ann Oncol (2015)